Morgan Stanley Initiates EMN At Overweight

Morgan Stanley is initiating coverage of Eastman Chemical Company EMN at Overweight. The stock is being added to Morgan Stanley's Best Ideas list. “We expect consensus forecasts to rise 10-20% in the near term,” Morgan Stanley writes. “Also, we believe Eastman's re-balancing of its portfolio has created a higher-quality business with better returns, which will result in significant multiple expansion. “EMN's analyst meeting on March 1 is the catalyst we think will drive consensus upgrades and mark the start of the re-rating. Our $110 price target suggests 25% upside potential.” Eastman Chemical currently trades at $91.47.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst RatingsDiversified Chemicalseastman chemicalMaterialsMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!